Bloodstream Infections With Candida auris Among Children in Colombia: Clinical Characteristics and Outcomes of 34 Cases
- 6 May 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of the Pediatric Infectious Diseases Society
- Vol. 10 (2), 151-154
- https://doi.org/10.1093/jpids/piaa038
Abstract
Background: Candida auris is an emerging multidrug-resistant yeast that can cause invasive infections and healthcare-associated outbreaks. Here, we describe 34 cases of pediatric C. auris bloodstream infections (BSIs) identified during July 2014–October 2017 in 2 hospitals in Colombia. Methods: We conducted a retrospective review of microbiology records for possible C. auris cases in 2 hospitals in Barranquilla and Cartagena. BSIs that occurred in patients aged <18 years confirmed as C. auris were included in this analysis. Results: We identified 34 children with C. auris BSIs. Twenty-two (65%) patients were male, 21% were aged 1 year. Underlying conditions included preterm birth (26%), being malnourished (59%), cancer (12%), solid-organ transplant (3%), and renal disease (3%). Eighty-two percent had a central venous catheter (CVC), 82% were on respiratory support, 56% received total parenteral nutrition (TPN), 15% had a surgical procedure, and 9% received hemodialysis. Preinfection inpatient stay was 22 days (interquartile range, 19–33 days), and in-hospital mortality was 41%. Conclusions: Candida auris affects children with a variety of medical conditions including prematurity and malignancy, as well as children with CVCs and those who receive TPN. Mortality was high, with nearly half of patients dying before discharge. However, unlike most other Candida species, C. auris can be transmitted in healthcare settings, as suggested by the close clustering of cases in time at each of the hospitals. Candida auris is an emerging multidrug-resistant yeast that can cause invasive infections and healthcare-associated outbreaks. This report describes 34 cases of pediatric C. auris bloodstream infections, identified in two hospitals in Colombia, South America.Keywords
This publication has 10 references indexed in Scilit:
- Erratum: Candida auris: The recent emergence of a multidrug-resistant fungal PathogenMedical Mycology, 2019
- A Candida auris Outbreak and Its Control in an Intensive Care SettingThe New England Journal of Medicine, 2018
- Candida auris: The recent emergence of a multidrug-resistant fungal pathogenMedical Mycology, 2018
- Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B ResistanceClinical Infectious Diseases, 2018
- Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015Journal of the Pediatric Infectious Diseases Society, 2018
- Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida aurisJournal of Clinical Microbiology, 2017
- Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities — United States, June 2016–May 2017Morbidity and Mortality Weekly Report (MMWR), 2017
- Invasive Infections with Multidrug-Resistant Yeast Candida auris, ColombiaEmerging Infectious Diseases, 2017
- First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemiaJournal of Infection, 2016
- New Clonal Strain ofCandida auris, Delhi, IndiaEmerging Infectious Diseases, 2013